REA, Silvio
 Distribuzione geografica
Continente #
NA - Nord America 217
EU - Europa 51
AS - Asia 49
SA - Sud America 3
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 322
Nazione #
US - Stati Uniti d'America 212
SG - Singapore 26
IT - Italia 15
IN - India 13
UA - Ucraina 11
SE - Svezia 10
CN - Cina 9
FI - Finlandia 7
CA - Canada 3
AR - Argentina 2
IE - Irlanda 2
MX - Messico 2
RO - Romania 2
CL - Cile 1
DE - Germania 1
ES - Italia 1
EU - Europa 1
ID - Indonesia 1
NL - Olanda 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 322
Città #
Santa Clara 24
Fairfield 22
Chandler 21
Singapore 19
Ann Arbor 17
Houston 14
Ashburn 9
Cambridge 9
Princeton 8
San Paolo di Civitate 8
Beijing 7
Plano 7
Seattle 7
Lawrence 6
San Diego 6
Millbury 5
Wilmington 5
Woodbridge 5
Rome 4
Jacksonville 3
Toronto 3
Boston 2
Dublin 2
Federal 2
New York 2
Boardman 1
Bratislava 1
Bühl 1
Falls Church 1
Helsinki 1
Jakarta 1
Mexico City 1
Muizenberg 1
Naaldwijk 1
Philadelphia 1
Washington 1
West Lafayette 1
Totale 229
Nome #
null 52
Adjuvant ovarian suppression, high-dose chemotherapy and immunotherapy for premenopausal patients with high-risk breast cancer 47
Combined chemotherapy and differentiation therapy in the treatment of advanced non-small-cell lung cancer 42
Minimal residual disease in metastatic breast cancer: treatment with IFN-beta, retinoids, and tamoxifen. 39
Advanced carcinoma of the pancreas - Phase II study of combined chemotherapy, beta-interferon, and retinoids 38
Adjuvant Therapy In Surgically Resected Colon Cancer 35
Interferon-beta, retinoids, and tamoxifen in the treatment of metastatic breast cancer: a phase II study 23
Primitive sarcoma of the breast: New insight on the proper surgical management 15
Prospects for combined analyses of hadronic emission from y-ray sources in the Milky Way with CTA and KM3NeT 10
. Extended phase II study of maintenance immunotherapy in advancer Cancer. Proc Am Ass Cancer Res 53:5366, 2012 Abstract #5366 8
A multicenter¸open label phase II trial of liposomal doxorubicin (LD) and docetaxel (DX), followed by concurrent chemotherapy and radiation therapy in locally advanced high risk, early breast cancer (HRBC). A multicenter¸open label phase II trial of liposomal doxorubicin (LD) and docetaxel (DX), followed by concurrent chemotherapy and radiation therapy in locally advanced high risk, early breast cancer (HRBC). J Clin Oncol 30: 2012 (ASCO MEETING ABSTRACTS May 30, 2012:e11041 ASCO MEETING ABSTRACTS May 30, 2012:e11041 8
Triple-negative breast cancer: multipronged approach. single-arm pilot phase II study 7
Liposomal pegylated doxorubicin and oxaliplatin as salvage chemotherapy in patients with metastatic gastric cancer treated earlier 6
Vascular endothelial growth factor expression and T-regulatory cells in premenopausal breast cancer 6
Premenopausal hormone-responsive breast cancer with extensive axillary nodes involvement: total estrogen blockade and chemotherapy 6
Chemoembolization of unresectable hepatocellular carcinoma. decreased toxicity with slow-release doxorubicin‑eluting beads compared with lipiodol 4
Long term follow up of a multicenter phase II study of chemo-immunotherapy in the treatment of metastatic colorectal cancer (MCC). J Clin Oncol 29: 2011 (suppl; abstr…) 3
Astronomy potential of KM3NeT/ARCA 2
Totale 351
Categoria #
all - tutte 1.382
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.382


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202016 0 0 0 0 0 1 2 2 2 2 7 0
2020/202114 1 0 1 3 1 0 0 3 0 1 3 1
2021/202273 0 3 6 6 10 2 1 7 5 5 11 17
2022/202364 14 21 3 8 4 5 0 4 5 0 0 0
2023/202454 2 5 3 0 2 4 0 5 13 4 11 5
2024/202556 4 15 6 5 10 16 0 0 0 0 0 0
Totale 351